HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10
HTG Molecular Diagnostics (HTGM) will release its Q3 2020 financial results on November 10, 2020, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HTG Molecular Diagnostics (HTGM) will release its Q3 2020 financial results on November 10, 2020, after market close. Following this, management will hold a conference call at 4:30 PM ET to discuss the results and provide a corporate update. The company specializes in NGS-based molecular profiling using its proprietary HTG EdgeSeq technology, aimed at supporting precision medicine by identifying crucial biomarkers for treatment options.
Positive
- HTG is focused on advancing precision medicine through NGS-based molecular profiling.
- The proprietary HTG EdgeSeq technology aids in complex molecular profiling, enhancing its market position.
Negative
- None.
Details
News Market Reaction – HTGM
The recorded move for HTGM in the trading session of this news was -1.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TUCSON, Ariz., Oct. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the third quarter ended September 30, 2020 after the market close on Tuesday, November 10, 2020. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.
| Conference Call & Webcast Details | |
| Date: | Tuesday, November 10 |
| Time: | 4:30 pm Eastern Time |
| Toll Free: | 877-407-0789 |
| International: | 201-689-8562 |
| Conference ID: | 13711846 |
| Webcast: | http://public.viavid.com/index.php?id=141926 |
About HTG
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.